Facebook
Twitter
LinkedIn
Forward(Education and Consultative Services (formerly OERP) of UPMC Western Psychiatric Hospital) Microsoft Teams: How COVID-19 is Impacting People with Substance Use Disorders June 24, 2020
Introductory
The COVID-19 pandemic has led to global distress and disruption. People with substance use disorders and their
families may find this time especially challenging, as they deal with additional risk factors for contracting and
transmitting the virus, difficulties entering and maintaining recovery, and the decrease or loss of access to their
support systems. Additionally, as people find themselves spending more time alone, with massive shifts in structure and daily routine, they may also find themselves using alcohol or other drugs more frequently.
In this presentation, we will discuss these various challenges, along with ways to identify warning signs for
problematic substance use and when to refer for medical evaluation. We will also discuss ways to help individuals
and families respond positively to these challenges
Target Audience
Physicians, Psychiatrists, Psychologists, Behavioral Health Therapists I, Behavioral Health Therapists II, Behavioral Health Therapists III, Nurses, Social Workers, Program Leadership
Learning Objectives
By the completion of this session, participants should be able to:
1. Describe challenges that may be magnified for people with substance use disorders during a pandemic, as
well as the impact on families and children
2. Identify risk factors and warning signs for problematic substance use, and recognize symptoms that might
warrant medical intervention
3. Utilize virtual resources to help people with substance use disorders during a pandemic
Jody Glance, MD, UPMC Medical Director of Addiction Medicine Services, Assistant Professor of Psychiatry at University of Pittsburgh School of Medicine Associate Director, Medical Student Education, Department of Psychiatry, University of Pittsburgh School of Medicine Pittsburgh, PA
Faculty Disclosure
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any proprietary entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients to disclose.
Accreditation and credit designation
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh School designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 1.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 1.00 Attendance